SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-287292
Filing Date
2019-11-07
Accepted
2019-11-07 16:10:13
Documents
57
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d806911d10q.htm   iXBRL 10-Q 2360968
2 EX-10.1 d806911dex101.htm EX-10.1 18222
3 EX-31.1 d806911dex311.htm EX-31.1 11118
4 EX-31.2 d806911dex312.htm EX-31.2 11101
5 EX-32.1 d806911dex321.htm EX-32.1 6425
  Complete submission text file 0001193125-19-287292.txt   6941110

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gbt-20190930.xsd EX-101.SCH 32561
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20190930_cal.xml EX-101.CAL 44818
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20190930_def.xml EX-101.DEF 138259
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20190930_lab.xml EX-101.LAB 319821
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20190930_pre.xml EX-101.PRE 248806
49 EXTRACTED XBRL INSTANCE DOCUMENT d806911d10q_htm.xml XML 1243495
Mailing Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 191200404
SIC: 2834 Pharmaceutical Preparations